Citigroup’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $143K | Sell |
38,274
-15,908
| -29% | -$59.3K | ﹤0.01% | 3514 |
|
|
2025
Q1 | $150K | Sell |
54,182
-4,998
| -8% | -$13.8K | ﹤0.01% | 3600 |
|
|
2024
Q4 | $328K | Buy |
59,180
+9,525
| +19% | +$52.8K | ﹤0.01% | 3281 |
|
|
2024
Q3 | $414K | Sell |
49,655
-311,425
| -86% | -$2.6M | ﹤0.01% | 3106 |
|
|
2024
Q2 | $2.46M | Buy |
361,080
+203,519
| +129% | +$1.39M | ﹤0.01% | 1612 |
|
|
2024
Q1 | $1.03M | Buy |
157,561
+150,467
| +2,121% | +$987K | ﹤0.01% | 2338 |
|
|
2023
Q4 | $46K | Buy |
7,094
+6,257
| +748% | +$40.6K | ﹤0.01% | 3821 |
|
|
2023
Q3 | $4.21K | Sell |
837
-13,672
| -94% | -$68.8K | ﹤0.01% | 4023 |
|
|
2023
Q2 | $127K | Sell |
14,509
-30,884
| -68% | -$270K | ﹤0.01% | 3456 |
|
|
2023
Q1 | $537K | Sell |
45,393
-655
| -1% | -$7.76K | ﹤0.01% | 2493 |
|
|
2022
Q4 | $469K | Buy |
46,048
+45,347
| +6,469% | +$462K | ﹤0.01% | 2577 |
|
|
2022
Q3 | $4K | Buy |
701
+182
| +35% | +$1.04K | ﹤0.01% | 4539 |
|
|
2022
Q2 | $1K | Sell |
519
-548
| -51% | -$1.06K | ﹤0.01% | 5284 |
|
|
2022
Q1 | $3K | Sell |
1,067
-3,219
| -75% | -$9.05K | ﹤0.01% | 5160 |
|
|
2021
Q4 | $30K | Buy |
4,286
+2,694
| +169% | +$18.9K | ﹤0.01% | 4503 |
|
|
2021
Q3 | $17K | Buy |
1,592
+1,177
| +284% | +$12.6K | ﹤0.01% | 4547 |
|
|
2021
Q2 | $5K | Sell |
415
-163
| -28% | -$1.96K | ﹤0.01% | 5171 |
|
|
2021
Q1 | $13K | Buy |
+578
| New | +$13K | ﹤0.01% | 4833 |
|